Brenda J. Bergink-Voorthuis

Brenda J. Bergink-Voorthuis

Auto-generated profile, based on publicly available information

Brenda J. Bergink-Voorthuis

Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Osteoporosis International
Verified
Journal Article
Open access
PDF file
WNW. S. Nijmeijer
W. S. Nijmeijer
BVB. J. Voorthuis
B. J. Voorthuis
CGC. G. M. Groothuis-Oudshoorn
C. G. M. Groothuis-Oudshoorn
FWF. S. Würdemann
F. S. Würdemann
DVDetlef Van der Velde
Detlef Van der Velde
OGon behalf of the Dutch Hip Fracture Audit Taskforce Indicators Group
on behalf of the Dutch Hip Fracture Audit Taskforce Indicators Group
Summary The AHFS90 was developed for the prediction of early mortality in patients ≥ 90 years undergoing hip fracture surgery. The AHFS90 has a good accuracy and in most risk categories a good calibration. In our study population, the AHFS90 yielded a maximum prediction of early mortality of 64.5%. Purpose Identifying hip fracture patients with a high risk of early mortality after surgery could help make treatment decisions and information about the prognosis. This study aims to develop and validate a risk score for predicting early mortality in patients ≥ 90 years undergoing hip fracture surgery (AHFS90). Methods Patients ≥ 90 years, surgically treated for a hip fracture, were included. A selection of possible predictors for mortality was made. Missing data were subjected to multiple imputations using chained equations. Logistic regression was performed to develop the AHFS90, which was internally and externally validated. Calibration was assessed using a calibration plot and comparing observed and predicted risks. Results One hundred and two of the 922 patients (11.1%) died ≤ 30 days following hip fracture surgery. The AHFS90 includes age, gender, dementia, living in a nursing home, ASA score, and hemoglobin level as predictors for early mortality. The AHFS90 had good accuracy (area under the curve 0.72 for geographic cross validation). Predicted risks correspond with observed risks of early mortality in four risk categories. In two risk categories, the AHFS90 overestimates the risk. In one risk category, no mortality was observed; therefore, no analysis was possible. The AHFS90 had a maximal prediction of early mortality of 64.5% in this study population. Conclusion The AHFS90 accurately predicts early mortality after hip fracture surgery in patients ≥ 90 years of age. Predicted risks correspond to observed risks in most risk categories. In our study population, the AHFS90 yielded a maximum prediction of early mortality of 64.5%.

8 December 2021 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Open access
PDF file
NKNiels Kant
Niels Kant
GPGuido M. Peters
Guido M. Peters
BVBrenda J. Voorthuis
Brenda J. Voorthuis
CGCatharina G. M. Groothuis-Oudshoorn
Catharina G. M. Groothuis-Oudshoorn
MKMark V. Koning
Mark V. Koning
CDCarine J. M. Doggen
Carine J. M. Doggen
Our aim was to determine the agreement of heart rate (HR) and respiratory rate (RR) measurements by the Philips Biosensor with a reference monitor (General Electric Carescape B650) in severely obese patients during and after bariatric surgery. Additionally, sensor reliability was assessed. Ninety-four severely obese patients were monitored with both the Biosensor and reference monitor during and after bariatric surgery. Agreement was defined as the mean absolute difference between both monitoring devices. Bland Altman plots and Clarke Error Grid analysis (CEG) were used to visualise differences. Sensor reliability was reflected by the amount, duration and causes of data loss. The mean absolute difference for HR was 1.26 beats per minute (bpm) (SD 0.84) during surgery and 1.84 bpm (SD 1.22) during recovery, and never exceeded the 8 bpm limit of agreement. The mean absolute difference for RR was 1.78 breaths per minute (brpm) (SD 1.90) during surgery and 4.24 brpm (SD 2.75) during recovery. The Biosensor’s RR measurements exceeded the 2 brpm limit of agreement in 58% of the compared measurements. Averaging 15 min of measurements for both devices improved agreement. CEG showed that 99% of averaged RR measurements resulted in adequate treatment. Data loss was limited to 4.5% of the total duration of measurements for RR. No clear causes for data loss were found. The Biosensor is suitable for remote monitoring of HR, but not RR in morbidly obese patients. Future research should focus on improving RR measurements, the interpretation of continuous data, and development of smart alarm systems.

1 April 2026 in Patient Education and Counseling
Verified
Journal Article
Open access
SKSneha Kannan
Sneha Kannan
BBBrenda J. Bergink-Voorthuis
Brenda J. Bergink-Voorthuis
CGCatharina G.M. Groothuis-Oudshoorn
Catharina G.M. Groothuis-Oudshoorn
KLKelly M. de Ligt
Kelly M. de Ligt
JTJanine A. van Til
Janine A. van Til
As Patient-Reported Outcome Measures (PROMs) become integrated into clinical care, interest grows in identifying effective visualization formats. Evidence on formats supporting user preference and comprehension remains limited. Moreover, communication of uncertainty around predicted PROMs remains underexplored. This review evaluates quantitative studies on PROM visualization across clinical domains, focusing on observed past and current scores as well as predicted scores at individual and group levels. This review followed PRISMA guidelines and was registered in PROSPERO (CRD42024505034). Systematic searches of PubMed, Scopus, and Web of Science were conducted for quantitative studies published between 2014 and 2024, assessing user preferences and comprehension for the visualization of PROMs. Two independent reviewers screened articles, extracted data, and assessed study quality using the Mixed Methods Appraisal Tool (MMAT). Data were synthesized descriptively according to outcome and visualization type. Thirteen of the 7973 identified studies met inclusion and quality criteria. Seven studies assessed preferences, and seven studies assessed comprehension of visualization formats. For individual-level data, bar charts were preferred over line graphs in three studies, and heat maps in one study; for group-level data, two studies found pie charts preferred over bar charts and icon arrays. For comprehension, bar charts and line graphs were generally well understood, with accuracy ranging from 49 to 100% among patients and 90-100% among clinicians for individual-level data. For group-level data, pie charts were correctly interpreted by 52-95% of the population. One study assessed visualization of predicted PROMs, which patients found difficult to interpret. Preferences and comprehension of PROM visualizations vary by format, data type, and users. While bar charts, line graphs, and pie charts are preferred, no one-size-fits-all approach exists. Visualization of predicted outcomes remains underexplored. Future research should study preferences for and comprehension of predicted PROM visualizations and apply user-centered design to support clinical decision-making.

20 October 2026 in ESMO Real World Data and Digital Oncology
Verified
Journal Article
Open access
LHL.A. Hoveling
L.A. Hoveling
BBB.J. Bergink-Voorthuis
B.J. Bergink-Voorthuis
JVJ.R.G. van Vlaardingen
J.R.G. van Vlaardingen
RVR.H.A. Verhoeven
R.H.A. Verhoeven
AWA.D. Wagner
A.D. Wagner
SSSabine Siesling
Sabine Siesling